Additionally, it has been reported in individuals with the autoimmune disorder systemic lupus erythematosus that the level of FcγRIIB expression on B cells is reduced (104) further highlighting that the level of FcγRIIB expression between individuals can vary, which could impact the agonistic activity of mAb in humans. Here, FCGR2B is linked to systemic lupus erythematosus.